• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amdocs Limited Reports Third Quarter Fiscal 2024 Results

    8/7/24 4:01:00 PM ET
    $DOX
    EDP Services
    Technology
    Get the next $DOX alert in real time by email

    Record Quarterly Revenue of $1.25 Billion, up 1.1% YoY as Reported and 1.8% YoY in Constant Currency(1)

    Record 12-Month Backlog of $4.25 Billion, up 2.7% YoY

    Updates Fiscal 2024 Outlook:

    Expects Revenue Growth of 1.9%-2.7% YoY as Reported

    Reiterates Midpoint of Revenue Growth Outlook in Constant Currency(1) while Tightening Expected Range to 2.3%-3.1% YoY

    On-track to Achieve Accelerated Profitability Targets in Fiscal 2024

    Expects GAAP Diluted EPS Growth of 7.4%-9.2% YoY

    Reiterates Midpoint of Non-GAAP Diluted EPS Growth Outlook while Tightening Expected Range to 8.5%-9.5% YoY

    Third Quarter Fiscal 2024 Highlights

    (All comparisons are against the prior year)

    • Record revenue of $1,250 million, up 1.1% as reported and up 1.8% in constant currency(1); revenue was at the midpoint of the $1,235-$1,275 million guidance range, adjusting for a negative impact from foreign currency movements of approximately $5 million compared to our guidance assumptions

    • Record managed services revenue of $741 million, equivalent to approximately 59% of total revenue

    • GAAP diluted EPS of $1.21, including a restructuring charge of 11 cents per share, without which GAAP diluted EPS would have been at the high end of the guidance range of $1.24-$1.32

    • Non-GAAP diluted EPS of $1.62, at the higher end of the guidance range of $1.57-$1.63

    • GAAP operating income of $176 million; GAAP operating margin of 14.1%, up 160 basis points sequentially and down 70 basis points as compared to last year's third fiscal quarter

    • Non-GAAP operating income of $232 million; non-GAAP operating margin of 18.6%, up 80 basis points as compared to last year's third fiscal quarter and up 20 basis points sequentially, reflecting a continued focus on operational excellence

    • Free cash flow of $175 million, comprised of cash flow from operations of $191 million, less $16 million in net capital expenditures and other(2), including approximately $18 million of restructuring payments

    • Repurchased $169 million of ordinary shares during the third fiscal quarter

    • Record twelve-month backlog of $4.25 billion, up approximately 2.7% as compared to last year's third fiscal quarter and up approximately $20 million sequentially

    1. Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior period

    2. Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding)

    3. Expected total shareholder return assumes Non-GAAP EPS growth plus dividend yield

    JERSEY CITY, NJ / ACCESSWIRE / August 7, 2024 / Amdocs Limited (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today reported operating results for the three months ended June 30, 2024.

    "We delivered solid Q3 results, highlighted by accelerated profitability gains and record revenue, in line with the midpoint of our guidance after currency adjustments. Sales momentum was healthy as we focused on delivering value in our strategic domains of cloud, digital modernization, 5G and fiber monetization, network automation and Generative AI. Notably, customer demand for Amdocs' cloud solutions remains especially strong, highlighted by the significant 5-year cloud deal we previously announced with AT&T, as well as newly signed agreements to support the cloud migration journeys of TELUS in Canada and Vodafone Ziggo in Netherlands. I am also happy to announce that a leading global operator has chosen to integrate Amdocs' Gen AI, telco-specific amAIz platform in its business operations. I believe this important award in partnership with NVIDIA demonstrates our commitment to innovation and the unique role Amdocs can play as one of the leading Gen AI technology enablers in the telecommunications industry today," said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

    "The ongoing implementation of automation, AI and Gen AI, and other sophisticated tools continues to drive cost and efficiency benefits across our business, the cumulative effects of which translated to accelerated profitability gains in Q3. Our managed services offering is resonating in the market, highlighted by record quarterly revenue in Q3 and significant multi-year agreements to support the cloud migration journeys of AT&T, Telus and Vodafone Ziggo. Demonstrating our confidence in Amdocs' unique business model, and the future success of the company, we also increased our pace of buyback activity in Q3, repurchasing approximately $169 million of Amdocs shares," said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.

    Sheffer concluded, "We continue to see a healthy pipeline of opportunities within our strategic growth domains, and our market win rate remains high as we leverage our pedigree for innovation and technology, market-leading portfolio, best-in-class execution and highly talented people. Nonetheless, we continue to operate in a challenging industry demand environment which is yet to improve. We are reiterating the midpoint of our constant currency(1) revenue growth expectations in fiscal 2024, which includes another year of double-digit growth in cloud. Moreover, our profitability gains are on-track with our targets, and we are positioned to deliver double-digit expected total shareholder returns(3) for the fourth year running."

    In Remembrance

    Amdocs announces with great sadness that Mr. Richard T.C. LeFave, a member of our Board of Directors, passed away on July 27, 2024. Mr. LeFave served as a director of Amdocs since 2011 and was the Chairman of the Technology and Innovation Committee and a member of several board committees. Mr. LeFave made invaluable contributions to the success of Amdocs through his mentorship and guidance throughout the years. The Board of Directors and our employees extend their deepest condolences to Mr. LeFave's family, friends, and colleagues.

    Revenue

    (All comparisons are against the prior year period)

    In millions

    Three months ended

    June 30, 2024

    Actual

    Guidance

    Revenue

    $

    1,250

    $1,235 - $1,275

    Revenue Growth, as reported

    1.1%

    Revenue Growth, constant currency (1)

    1.8%

    • Revenue for the third fiscal quarter of 2024 was at the midpoint of Amdocs' guidance, adjusting for an unfavorable impact from foreign currency movements of approximately $5 million relative to our guidance assumptions

    • Revenue for the third fiscal quarter includes an unfavorable impact from foreign currency movements of approximately $4 million relative to the second quarter of fiscal 2024

    Net Income and Earnings Per Share

    In thousands, except per share data

    Three months ended

    June 30,

    2024

    2023

    GAAP Measures

    Net Income

    $

    140,998

    $

    160,115

    Net Income attributable to Amdocs Limited

    $

    140,289

    $

    159,428

    Diluted earnings per share

    $

    1.21

    $

    1.32

    Non-GAAP Measures

    Non-GAAP Net Income

    $

    187,807

    $

    189,605

    Non-GAAP Net Income attributable to Amdocs Limited

    $

    187,098

    $

    188,918

    Non-GAAP Diluted earnings per share

    $

    1.62

    $

    1.57

    • Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition related liabilities measured at fair value, equity-based compensation expenses, and other, net of related tax effects, in all the periods presented, and in the three months ended June 30, 2024, also excludes restructuring charges net of related tax effects

    For further details of the reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

    Capital Allocation

    • Quarterly Cash Dividend Program: On August 7, 2024, the Board approved the Company's next quarterly cash dividend payment of $0.479 per share, and set September 30, 2024 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on October 25, 2024

    • Share Repurchase Activity: Repurchased $169 million of ordinary shares during the third quarter of fiscal 2024

    Twelve-month Backlog

    Twelve-month backlog was a record $4.25 billion at the end of the third quarter of fiscal 2024, up approximately 2.7% as compared to last year's third fiscal quarter. Twelve-month backlog includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities.

    Fourth Quarter Fiscal Year Outlook

    In millions, except per share data

    Q4 - 2024

    Revenue

    $1,240-$1,280

    GAAP Diluted earnings per share

    $1.34-$1.42

    Non-GAAP Diluted earnings per share

    $1.67-$1.73

    • Fourth quarter revenue guidance assumes immaterial sequential impact from foreign currency fluctuations as compared to the third quarter of fiscal 2024

    • Fourth quarter non-GAAP diluted EPS guidance excludes equity-based compensation expense of approximately $0.18-$0.20 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.11 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

    • GAAP diluted EPS guidance does not include the impact of future expected restructuring charges

    Full Year Fiscal 2024 Outlook

    FY 2024 - Year-over -Year growth

    Current guidance

    Previous guidance

    Revenue Growth, as reported

    1.9%-2.7%

    1.6%-3.6%

    Revenue Growth, constant currency (1)

    2.3%-3.1%

    1.7%-3.7%

    GAAP Diluted earnings per share

    7.4%-9.2%

    7.0%-13.0%

    Non-GAAP Diluted earnings per share

    8.5%-9.5%

    7.0%-11.0%

    FY 2024, in millions

    Current guidance

    Previous guidance

    Free Cash Flow (2)

    $

    700

    $

    700

    • Full year fiscal 2024 revenue guidance incorporates an expected unfavorable impact from foreign currency fluctuations of approximately 0.4% year-over-year, as compared with an unfavorable impact of about 0.1% year-over-year previously

    • Non-GAAP diluted earnings per share growth excludes equity-based compensation expense of approximately $0.72-$0.74 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.46 per share, restructuring charges of $0.35, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

    • GAAP diluted EPS guidance does not include the impact of future expected restructuring charges

    • Non-GAAP operating margin is anticipated to be within a range of 18.1% to 18.7% for the full year fiscal 2024

    • Non-GAAP operating margin is comprised of GAAP operating margin, excluding amortization on purchased intangible assets and other, equity-based compensation expense, restructuring charges, and changes in certain acquisitions related liabilities measured at fair value

    • Non-GAAP effective tax rate is anticipated to be within a range of 13% to 17% for the full year fiscal 2024

    • Free cash flow(2) is comprised of cash flow from operations, less net capital expenditures and other, and excludes payments related to restructuring charges

    The forward looking statements regarding our fourth fiscal quarter 2024 and full year fiscal 2024 guidance take into consideration the Company's current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, global or regional events, such as the COVID-19 pandemic and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continue to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.

    Conference Call and Earnings Webcast Presentation Details

    Amdocs will host a conference call and earnings webcast presentation on August 7, 2024 at 5:00 p.m. Eastern Time to discuss the Company's third quarter of fiscal 2024 results.

    To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.

    Non-GAAP Financial Measures
    This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, revenue on a constant currency(1) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:

    • amortization of purchased intangible assets and other acquisition-related costs;

    • changes in certain acquisition-related liabilities measured at fair value;

    • restructuring and unusual charges or benefits;

    • equity-based compensation expense;

    • other; and

    • tax effects related to the above.

    Free cash flow equals cash generated by operating activities less net capital expenditures and other. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

    Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow(2), revenue on a constant currency(1) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

    For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, restructuring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

    Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

    Supporting Resources

    • Keep up with Amdocs news by visiting the Company's website

    • Subscribe to Amdocs' RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

    About Amdocs

    Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our approximately 29,000 employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.89 billion in fiscal 2023.

    For more information, visit Amdocs at www.amdocs.com.

    This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events and the COVID-19 pandemic, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2023 filed on December 13, 2023 and our Form 6-K furnished for the first quarter of fiscal 2024 on February 20, 2024 and for the second quarter of fiscal 2024 filed on May 20, 2024.

    Contact:
    Matthew Smith
    Head of Investor Relations
    Amdocs
    314-212-8328
    E-mail: [email protected]

    AMDOCS LIMITED
    Consolidated Statements of Income
    (In thousands, except per share data)

    Three months ended
    June 30,

    Nine months ended
    June 30,

    2024

    2023

    2024

    2023

    Revenue

    $

    1,250,059

    $

    1,235,962

    $

    3,741,107

    $

    3,644,986

    Operating expenses:

    Cost of revenue

    809,970

    804,007

    2,424,710

    2,356,341

    Research and development

    90,368

    92,162

    270,729

    277,162

    Selling, general and administrative

    144,027

    143,777

    434,140

    430,327

    Amortization of purchased intangible assets and other

    15,111

    13,302

    47,719

    41,555

    Restructuring charges

    14,715

    -

    47,875

    24,536

    1,074,191

    1,053,248

    3,225,173

    3,129,921

    Operating income

    175,868

    182,714

    515,934

    515,065

    Interest and other expense, net

    (6,872

    )

    (4,421

    )

    (28,300

    )

    (12,322

    )

    Income before income taxes

    168,996

    178,293

    487,634

    502,743

    Income taxes

    27,998

    18,178

    78,489

    62,447

    Net income

    $

    140,998

    $

    160,115

    $

    409,145

    $

    440,296

    Net income attributable to noncontrolling interests

    709

    687

    2,389

    1,598

    Net income attributable to Amdocs Limited

    $

    140,289

    $

    159,428

    $

    406,756

    $

    438,698

    Basic earnings per share attributable to Amdocs Limited

    $

    1.22

    $

    1.33

    $

    3.50

    $

    3.65

    Diluted earnings per share attributable to Amdocs Limited

    $

    1.21

    $

    1.32

    $

    3.48

    $

    3.62

    Cash dividends declared per ordinary share

    $

    0.479

    $

    0.435

    $

    1.393

    $

    1.265

    Basic weighted average number of shares outstanding

    114,973

    119,520

    116,075

    120,230

    Diluted weighted average number of shares outstanding

    115,548

    120,351

    116,738

    121,070

    AMDOCS LIMITED
    Selected Financial Metrics
    (In thousands, except per share data)

    Three months ended
    June 30,

    Nine months ended
    June 30,

    2024

    2023

    2024

    2023

    Revenue

    $

    1,250,059

    $

    1,235,962

    $

    3,741,107

    $

    3,644,986

    Non-GAAP operating income

    232,390

    220,222

    687,065

    647,497

    Non-GAAP net income

    187,807

    189,605

    555,260

    545,445

    Non-GAAP net income attributable to Amdocs Limited

    187,098

    188,918

    552,871

    543,847

    Non-GAAP diluted earnings per share

    $

    1.62

    $

    1.57

    $

    4.74

    $

    4.49

    Diluted weighted average number of shares outstanding

    115,548

    120,351

    116,738

    121,070

    Free Cash Flows
    (In thousands)

    Three months ended
    June 30,

    Nine months ended
    June 30,

    2024

    2023

    2024

    2023

    Net Cash Provided by Operating Activities

    $

    191,462

    $

    172,557

    $

    506,506

    $

    550,259

    Purchases of property and equipment, net (a)

    (16,337

    )

    (28,983

    )

    (79,683

    )

    (97,805

    )

    Free Cash Flow

    $

    175,125

    $

    143,574

    $

    426,823

    $

    452,454

    (a) The amounts under "Purchase of property and equipment, net", include immaterial proceeds from sale of property and equipment for the nine months ended June 30, 2024 and 2023, respectively.

    AMDOCS LIMITED
    Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
    (In thousands)

    Three Months Ended June 30, 2024

    GAAP

    Amortization of purchased intangible assets and other

    Equity based compensation expense

    Changes in certain acquisitions related liabilities measured at fair value

    Restructuring charges

    Tax
    effect

    Non-GAAP

    Operating expenses:

    Cost of revenue

    $

    809,970

    $

    -

    $

    (13,351

    )

    $

    (584

    )

    $

    -

    $

    -

    $

    796,035

    Research and development

    90,368

    (2,166

    )

    88,202

    Selling, general and administrative

    144,027

    (10,595

    )

    133,432

    Amortization of purchased intangible assets and other

    15,111

    (15,111

    )

    -

    Restructuring charges

    14,715

    (14,715

    )

    -

    Total operating expenses

    1,074,191

    (15,111

    )

    (26,112

    )

    (584

    )

    (14,715

    )

    -

    1,017,669

    Operating income

    175,868

    15,111

    26,112

    584

    14,715

    -

    232,390

    Interest and other expense, net

    (6,872

    )

    (6,872

    )

    Income taxes

    27,998

    9,713

    37,711

    Net income

    140,998

    15,111

    26,112

    584

    14,715

    (9,713

    )

    187,807

    Net income attributable to noncontrolling interests

    709

    709

    Net income attributable to Amdocs Limited

    $

    140,289

    $

    15,111

    $

    26,112

    $

    584

    $

    14,715

    $

    (9,713

    )

    $

    187,098

    Three Months Ended June 30, 2023

    GAAP

    Amortization of purchased intangible assets and other

    Equity based compensation expense

    Changes in certain acquisitions related liabilities measured at fair value

    Other

    Tax
    effect

    Non-GAAP

    Operating expenses:

    Cost of revenue

    $

    804,007

    $

    -

    $

    (11,852

    )

    $

    (152

    )

    $

    -

    $

    -

    $

    792,003

    Research and development

    92,162

    (2,037

    )

    90,125

    Selling, general and administrative

    143,777

    (10,165

    )

    133,612

    Amortization of purchased intangible assets and other

    13,302

    (13,302

    )

    -

    Total operating expenses

    1,053,248

    (13,302

    )

    (24,054

    )

    (152

    )

    -

    1,015,740

    Operating income

    182,714

    13,302

    24,054

    152

    -

    220,222

    Interest and other expense, net

    (4,421

    )

    508

    (3,913

    )

    Income taxes

    18,178

    8,526

    26,704

    Net income

    160,115

    13,302

    24,054

    152

    508

    (8,526

    )

    189,605

    Net income attributable to noncontrolling interests

    687

    687

    Net income attributable to Amdocs Limited

    $

    159,428

    $

    13,302

    $

    24,054

    $

    152

    $

    508

    $

    (8,526

    )

    $

    188,918

    AMDOCS LIMITED
    Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
    (In thousands)

    Nine Months Ended June 30, 2024

    GAAP

    Amortization of purchased intangible assets and other

    Equity based compensation expense

    Changes in certain acquisitions related liabilities measured at fair value

    Restructuring charges

    Other

    Tax
    effect

    Non-GAAP

    Operating expenses:

    Cost of revenue

    $

    2,424,710

    $

    -

    $

    (40,126

    )

    $

    3,000

    $

    -

    $

    -

    $

    -

    $

    2,387,584

    Research and development

    270,729

    (6,289

    )

    264,440

    Selling, general and administrative

    434,140

    (32,122

    )

    402,018

    Amortization of purchased intangible assets and other

    47,719

    (47,719

    )

    -

    Restructuring charges

    47,875

    (47,875

    )

    -

    Total operating expenses

    3,225,173

    (47,719

    )

    (78,537

    )

    3,000

    (47,875

    )

    -

    3,054,042

    Operating income

    515,934

    47,719

    78,537

    (3,000

    )

    47,875

    -

    687,065

    Interest and other expense, net

    (28,300

    )

    5,538

    (22,762

    )

    Income taxes

    78,489

    30,554

    109,043

    Net income

    409,145

    47,719

    78,537

    (3,000

    )

    47,875

    5,538

    (30,554

    )

    555,260

    Net income attributable to noncontrolling interests

    2,389

    2,389

    Net income attributable to Amdocs Limited

    $

    406,756

    $

    47,719

    $

    78,537

    $

    (3,000

    )

    $

    47,875

    $

    5,538

    $

    (30,554

    )

    $

    552,871

    Nine Months Ended June 30, 2023

    GAAP

    Amortization of purchased intangible assets and other

    Equity based compensation expense

    Changes in certain acquisitions related liabilities measured at fair value

    Restructuring charges

    Other

    Tax
    effect

    Non-GAAP

    Operating expenses:

    Cost of revenue

    $

    2,356,341

    $

    -

    $

    (30,568

    )

    $

    (1,436

    )

    $

    -

    $

    -

    $

    -

    $

    2,324,337

    Research and development

    277,162

    (5,224

    )

    271,938

    Selling, general and administrative

    430,327

    (29,113

    )

    401,214

    Amortization of purchased intangible assets and other

    41,555

    (41,555

    )

    -

    Restructuring charges

    24,536

    (24,536

    )

    -

    Total operating expenses

    3,129,921

    (41,555

    )

    (64,905

    )

    (1,436

    )

    (24,536

    )

    -

    2,997,489

    Operating income

    515,065

    41,555

    64,905

    1,436

    24,536

    -

    647,497

    Interest and other expense, net

    (12,322

    )

    508

    (11,814

    )

    Income taxes

    62,447

    27,791

    90,238

    Net income

    440,296

    41,555

    64,905

    1,436

    24,536

    508

    (27,791

    )

    545,445

    Net income attributable to noncontrolling interests

    1,598

    1,598

    Net income attributable to Amdocs Limited

    $

    438,698

    $

    41,555

    $

    64,905

    $

    1,436

    $

    24,536

    $

    508

    $

    (27,791

    )

    $

    543,847

    AMDOCS LIMITED
    Condensed Consolidated Balance Sheets
    (In thousands)

    As of

    June 30,
    2024

    September 30,
    2023

    ASSETS

    Current assets:

    Cash and cash equivalents

    $

    317,989

    $

    520,080

    Short-term interest-bearing investments

    184,182

    222,451

    Accounts receivable, net

    1,018,801

    944,477

    Prepaid expenses and other current assets

    242,797

    224,622

    Total current assets

    1,763,769

    1,911,630

    Property and equipment, net

    758,435

    790,923

    Lease assets

    162,573

    160,938

    Goodwill and other intangible assets, net

    3,019,770

    2,930,580

    Other noncurrent assets

    691,695

    631,582

    Total assets

    $

    6,396,242

    $

    6,425,653

    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current liabilities

    Accounts payable, accruals and other

    $

    1,248,961

    $

    1,142,781

    Lease liabilities

    40,077

    39,960

    Deferred revenue

    133,236

    170,634

    Total current liabilities

    1,422,274

    1,353,375

    Lease liabilities

    112,732

    121,654

    Long-term debt, net of unamortized debt issuance costs

    646,140

    645,696

    Other noncurrent liabilities

    668,276

    737,996

    Total Amdocs Limited Shareholders' equity

    3,504,462

    3,523,759

    Noncontrolling interests

    42,358

    43,173

    Total equity

    3,546,820

    3,566,932

    Total liabilities and equity

    $

    6,396,242

    $

    6,425,653

    AMDOCS LIMITED
    Consolidated Statements of Cash Flows
    (In thousands)

    Nine months ended
    June 30,

    2024

    2023

    Cash Flow from Operating Activities:

    Net income

    $

    409,145

    $

    440,296

    Reconciliation of net income to net cash provided by operating activities:

    Depreciation, amortization and impairment

    143,738

    148,412

    Amortization of debt issuance cost

    445

    432

    Equity-based compensation expense

    78,537

    64,905

    Deferred income taxes

    (12,347

    )

    (45,906

    )

    Loss from short-term interest-bearing investments

    5,212

    2,185

    Net changes in operating assets and liabilities, net of amounts acquired:

    Accounts receivable, net

    (88,805

    )

    (128,371

    )

    Prepaid expenses and other current assets

    (9,276

    )

    (34,353

    )

    Other noncurrent assets

    (21,207

    )

    3,410

    Lease assets and liabilities, net

    (10,440

    )

    (2,937

    )

    Accounts payable, accrued expenses and accrued personnel

    125,063

    108,922

    Deferred revenue

    (41,927

    )

    1,207

    Income taxes payable, net

    (62,328

    )

    (42,744

    )

    Other noncurrent liabilities

    (9,304

    )

    34,801

    Net cash provided by operating activities

    $

    506,506

    $

    550,259

    Cash Flow from Investing Activities:

    Purchase of property and equipment, net (a)

    (79,683

    )

    (97,805

    )

    Proceeds from sale of short-term interest-bearing investments

    49,516

    15,553

    Purchase of short-term interest-bearing investments

    (9,061

    )

    -

    Net cash paid for business acquisitions

    (86,824

    )

    (84,425

    )

    Other

    4,182

    (2,438

    )

    Net cash used in investing activities

    $

    (121,870

    )

    $

    (169,115

    )

    Cash Flow from Financing Activities:

    Repurchase of shares

    (443,316

    )

    (334,499

    )

    Proceeds from employee stock option exercises

    19,120

    45,976

    Payments of dividends

    (157,264

    )

    (147,679

    )

    Distribution to noncontrolling interests

    (3,204

    )

    (209

    )

    Payment of contingent consideration from a business acquisition

    (2,063

    )

    (453

    )

    Net cash used in financing activities

    $

    (586,727

    )

    $

    (436,864

    )

    Net decrease in cash and cash equivalents

    (202,091

    )

    (55,720

    )

    Cash and cash equivalents at beginning of period

    520,080

    573,377

    Cash and cash equivalents at end of period

    $

    317,989

    $

    517,657

    AMDOCS LIMITED
    Supplementary Information
    (In millions)

    Three months ended

    June 30,

    March 31,

    December 31,

    September 30,

    June 30,

    2024

    2024

    2023

    2023

    2023

    North America

    $

    828.8

    $

    823.2

    $

    838.1

    $

    834.4

    $

    830.9

    Europe

    175.9

    184.8

    181.4

    175.5

    187.3

    Rest of the World

    245.3

    237.8

    225.7

    232.6

    217.8

    Total Revenue

    $

    1,250.1

    $

    1,245.8

    $

    1,245.2

    $

    1,242.6

    $

    1,236.0

    Three months ended

    June 30,

    March 31,

    December 31,

    September 30,

    June 30,

    2024

    2024

    2023

    2023

    2023

    Managed Services Revenue

    $

    740.8

    $

    720.3

    $

    722.5

    $

    718.1

    $

    719.8

    as of

    June 30,

    March 31,

    December 31,

    September 30,

    June 30,

    2024

    2024

    2023

    2023

    2023

    12-Month Backlog

    $

    4,250

    $

    4,230

    $

    4,210

    $

    4,150

    $

    4,140

    SOURCE: Amdocs - IR



    View the original press release on accesswire.com

    Get the next $DOX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOX

    DatePrice TargetRatingAnalyst
    10/2/2024$100.00Buy
    Stifel
    12/1/2023$105.00Buy
    Jefferies
    5/16/2023$100.00 → $115.00Equal Weight → Overweight
    Barclays
    12/14/2021$91.00 → $86.00Overweight → Neutral
    JP Morgan
    8/5/2021$84.00 → $99.00Outperform
    Oppenheimer
    More analyst ratings

    $DOX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amdocs and Google Cloud Announce Partnership Expansion to Optimize 5G Network Operations with AI

      Amdocs will launch a solution using Google Cloud's AI and BigQuery to automate network operations and enhance customer experiences SUNNYVALE, Calif., Feb. 26, 2025 /PRNewswire/ -- Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, and Google Cloud today announced a major initiative to transform how telecommunications companies operate, maintain, and optimize critical 5G network ecosystems with AI. Using Google Cloud's Vertex AI and BigQuery, Amdocs will launch its new Network AIOps solution to help 5G network providers automate complex network operations, enhance service reliability, and improve customer experiences.

      2/26/25 4:00:00 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Files FY2024 Annual Report

      JERSEY CITY, NJ / ACCESSWIRE / December 17, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, has filed its Annual Report on Form 20-F for the fiscal year ended September 30, 2024 (including its financial statements for such year) with the U.S. Securities and Exchange Commission. The annual report is available through the Company's website (https://investors.amdocs.com/financial-information/sec-filings). Upon the request of a shareholder of the Company, the Company will promptly provide to such shareholder a copy of the 2024 annual report, free of charge.Supporting ResourcesKeep up with Amdocs news by visiting the company's website

      12/17/24 5:40:00 PM ET
      $DOX
      EDP Services
      Technology
    • Agentic Era Gives Birth to a New Branding Paradigm

      In the agentic era, service-intensive brands will need to consider the brand impact of the generative AI-based agents' personality on their customers in every interactionAmdocs global study reveals consumer preferences when interacting with AI agents and the key considerations brands must address during their journey into the agentic era JERSEY CITY, NJ / ACCESSWIRE / December 5, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today released a global study*, "Rethinking Brand and Customer Experience in the Agentic Era," commissioned by Amdocs in collaboration with McCann Tech agency and Coleman Parkes, which explores the impact o

      12/5/24 8:00:00 AM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Stifel initiated coverage on Amdocs with a new price target

      Stifel initiated coverage of Amdocs with a rating of Buy and set a new price target of $100.00

      10/2/24 7:26:06 AM ET
      $DOX
      EDP Services
      Technology
    • Jefferies initiated coverage on Amdocs with a new price target

      Jefferies initiated coverage of Amdocs with a rating of Buy and set a new price target of $105.00

      12/1/23 7:28:05 AM ET
      $DOX
      EDP Services
      Technology
    • Amdocs upgraded by Barclays with a new price target

      Barclays upgraded Amdocs from Equal Weight to Overweight and set a new price target of $115.00 from $100.00 previously

      5/16/23 7:13:02 AM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $DOX
    SEC Filings

    See more

    $DOX
    Financials

    Live finance-specific insights

    See more
    • SEC Form SC 13G/A filed by Amdocs Limited (Amendment)

      SC 13G/A - AMDOCS LTD (0001062579) (Subject)

      2/9/24 11:49:02 AM ET
      $DOX
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Amdocs Limited (Amendment)

      SC 13G/A - AMDOCS LTD (0001062579) (Subject)

      2/9/24 8:35:54 AM ET
      $DOX
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Amdocs Limited (Amendment)

      SC 13G/A - AMDOCS LTD (0001062579) (Subject)

      2/9/23 8:23:46 AM ET
      $DOX
      EDP Services
      Technology
    • SEC Form 6-K filed by Amdocs Limited

      6-K - AMDOCS LTD (0001062579) (Filer)

      5/7/25 8:01:03 PM ET
      $DOX
      EDP Services
      Technology
    • SEC Form 6-K filed by Amdocs Limited

      6-K - AMDOCS LTD (0001062579) (Filer)

      2/18/25 4:09:59 PM ET
      $DOX
      EDP Services
      Technology
    • SEC Form 6-K filed by Amdocs Limited

      6-K - AMDOCS LTD (0001062579) (Filer)

      12/23/24 4:05:02 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Reports Fourth Quarter & Fiscal Year 2024 Results

      Record Fiscal 2024 Revenue of $5.00 Billion, up 2.4% YoY as Reported and 2.7% YoYin Constant Currency(1)Successfully Achieved Accelerated Profitability Improvement TargetsInitiates Fiscal 2025 Outlook:Sharpening Focus on Strategic Priorities while Phasing Out Certain Non-Core, Low Margin Business ActivitiesAs a Result of which Expects Fiscal 2025 Revenue Outlook of (10.9)%-(7.7)% YoY as Reported and 1%-4.5% YoY in Pro Forma(2) Constant Currency(1)Targeting Double-Digit Total Shareholder Returns(3)(4), Supported by Enhanced Profitability ImprovementBoard Approves 10% Increase of Quarterly Cash Dividend(4)Full Year Fiscal 2024 Highlights(All comparisons are against the prior year)Record revenu

      11/12/24 4:01:00 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Reports Third Quarter Fiscal 2024 Results

      Record Quarterly Revenue of $1.25 Billion, up 1.1% YoY as Reported and 1.8% YoY in Constant Currency(1)Record 12-Month Backlog of $4.25 Billion, up 2.7% YoYUpdates Fiscal 2024 Outlook:Expects Revenue Growth of 1.9%-2.7% YoY as ReportedReiterates Midpoint of Revenue Growth Outlook in Constant Currency(1) while Tightening Expected Range to 2.3%-3.1% YoYOn-track to Achieve Accelerated Profitability Targets in Fiscal 2024Expects GAAP Diluted EPS Growth of 7.4%-9.2% YoYReiterates Midpoint of Non-GAAP Diluted EPS Growth Outlook while Tightening Expected Range to 8.5%-9.5% YoYThird Quarter Fiscal 2024 Highlights(All comparisons are against the prior year)Record revenue of $1,250 million, up 1.1% as

      8/7/24 4:01:00 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Reports Second Quarter 2024 Results

      Record Quarterly Revenue of $1.25 Billion, up 1.8% YoY as Reported and 2% YoY in Constant Currency(1)Record 12-Month Backlog of $4.23 Billion, up ~3% YoYUpdates Fiscal 2024 Outlook:Expects Revenue Growth of 1.6%-3.6% YoY as Reported and 1.7%-3.7% YoY in Constant Currency(1)On-track to Deliver Accelerated Profitability in Fiscal 2024Expects GAAP Diluted EPS Growth of 7.0%-13.0% andNon-GAAP Diluted EPS Growth of 7.0%-11.0%Second Quarter Fiscal 2024 Highlights(All comparisons are against the prior year)Record revenue of $1,246 million, up 1.8% as reported and up 2.0% in constant currency(1); revenue was slightly above the midpoint of $1,225-$1,265 million guidance range and includes an unfavora

      5/8/24 4:10:00 PM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Leadership Updates

    Live Leadership Updates

    See more
    • Amdocs Awarded Two 2024 AWS Partner Awards

      Amdocs recognized as winner in two categories - Industry Partner of the Year - Telco (Global) and Industry Partner of the Year - Telco (North America), recognizing top AWS Partners who enable telco customers to drive innovationJERSEY CITY, NJ / ACCESSWIRE / December 3, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced it is a recipient of the 2024 Geography and Global AWS Partner Award, recognizing leaders around the globe that are playing key roles in helping their customers drive innovation and build solutions on Amazon Web Services (AWS). Amdocs has been named winner in two categories - Industry Partner of the Ye

      12/3/24 4:30:00 PM ET
      $DOX
      EDP Services
      Technology